SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031249
Filing Date
2019-08-09
Accepted
2019-08-09 16:06:29
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 Q3 2019 10-Q enta-10q_20190630.htm   iXBRL 10-Q 2678658
2 EX-31.1 enta-ex311_12.htm EX-31.1 16205
3 EX-31.2 enta-ex312_11.htm EX-31.2 16191
4 EX-32.1 enta-ex321_10.htm EX-32.1 8930
5 GRAPHIC gf2fu0tmzn3e000001.jpg GRAPHIC 40546
  Complete submission text file 0001564590-19-031249.txt   8441138

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA enta-20190630.xsd EX-101.SCH 36720
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enta-20190630_cal.xml EX-101.CAL 44031
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enta-20190630_def.xml EX-101.DEF 128864
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE enta-20190630_lab.xml EX-101.LAB 323316
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enta-20190630_pre.xml EX-101.PRE 264413
11 EXTRACTED XBRL INSTANCE DOCUMENT enta-10q_20190630_htm.xml XML 1775306
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 191013008
SIC: 2834 Pharmaceutical Preparations